Veradigm Balance Sheet Health
Financial Health criteria checks 0/6
Insufficient data to determine the health of Veradigm
Key information
n/a
Debt to equity ratio
n/a
Debt
| Interest coverage ratio | n/a |
| Cash | n/a |
| Equity | n/a |
| Total liabilities | n/a |
| Total assets | n/a |
Recent financial health updates
Recent updates
Veradigm (NASDAQ:MDRX) Is Doing The Right Things To Multiply Its Share Price
Feb 28
Veradigm (NASDAQ:MDRX) Might Have The Makings Of A Multi-Bagger
Nov 10Veradigm's (NASDAQ:MDRX) Returns On Capital Are Heading Higher
Mar 06Is It Too Late To Consider Buying Veradigm Inc. (NASDAQ:MDRX)?
Feb 13Veradigm Inc. (NASDAQ:MDRX) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jan 22These 4 Measures Indicate That Veradigm (NASDAQ:MDRX) Is Using Debt Reasonably Well
Jan 04Returns Are Gaining Momentum At Allscripts Healthcare Solutions (NASDAQ:MDRX)
Dec 03Allscripts Healthcare reaffirms 2022 financial guidance; shares fall 2%
Sep 28Should You Think About Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Now?
Sep 17Investors Will Want Allscripts Healthcare Solutions' (NASDAQ:MDRX) Growth In ROCE To Persist
Aug 24We Think Allscripts Healthcare Solutions (NASDAQ:MDRX) Is Taking Some Risk With Its Debt
Jul 31Is Now An Opportune Moment To Examine Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?
Jun 15We Like These Underlying Return On Capital Trends At Allscripts Healthcare Solutions (NASDAQ:MDRX)
May 03Financial Position Analysis
Short Term Liabilities: Insufficient data to determine if MDRX's short term assets cover its short term liabilities.
Long Term Liabilities: Insufficient data to determine if MDRX's short term assets cover its long term liabilities.
Debt to Equity History and Analysis
Debt Level: Insufficient data to calculate MDRX's net debt to equity ratio to determine if it is satisfactory.
Reducing Debt: Insufficient data to determine if MDRX's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: Insufficient data to determine if MDRX's debt is well covered by operating cash flow.
Interest Coverage: Insufficient data to determine if MDRX's interest payments on its debt are well covered by EBIT.